LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about Carmot Therapeutics, Inc.…

Carmot Therapeutics, Inc. Tech Stack

Carmot Therapeutics, Inc. uses 8 technology products and services including Open Graph, MySQL, Twemoji, and more. Explore Carmot Therapeutics, Inc.'s tech stack below.

  • Open Graph
    Content Management System
  • MySQL
    Database
  • Twemoji
    Font Scripts
  • jQuery
    Javascript Libraries
  • AOS
    Javascript Libraries
  • PHP
    Programming Languages
  • Endurance Page Cache
    Web Platform Extensions
  • Jetpack
    Web Platform Extensions

Media & News

Carmot Therapeutics, Inc.'s Email Address Formats

Carmot Therapeutics, Inc. uses at least 2 format(s):
Carmot Therapeutics, Inc. Email FormatsExamplePercentage
FLast@carmot.usJDoe@carmot.us
56%
First.Last@carmot.usJohn.Doe@carmot.us
44%

Frequently Asked Questions

Where is Carmot Therapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign iconCarmot Therapeutics, Inc.'s main headquarters is located at Berkeley, California United States. The company has employees across 1 continents, including North America.

What is Carmot Therapeutics, Inc.'s stock symbol?

Minus sign iconPlus sign iconCarmot Therapeutics, Inc. is a publicly traded company; the company's stock symbol is CRMO.

What is Carmot Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign iconCarmot Therapeutics, Inc.'s official website is carmot-therapeutics.us and has social profiles on LinkedInCrunchbase.

What is Carmot Therapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign iconCarmot Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Carmot Therapeutics, Inc. have currently?

Minus sign iconPlus sign iconAs of February 2026, Carmot Therapeutics, Inc. has approximately 5 employees across 1 continents, including North America. Key team members include Associate Director, Accounting: J. N.Senior Clinical Trial Manager: L. A.Clinical Finance Manager: D. E.. Explore Carmot Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Carmot Therapeutics, Inc. belong to?

Minus sign iconPlus sign iconCarmot Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Carmot Therapeutics, Inc. use?

Minus sign iconPlus sign iconCarmot Therapeutics, Inc.'s tech stack includes Open GraphMySQLTwemojijQueryAOSPHPEndurance Page CacheJetpack.

What is Carmot Therapeutics, Inc.'s email format?

Minus sign iconPlus sign iconCarmot Therapeutics, Inc.'s email format typically follows the pattern of FLast@carmot.us. Find more Carmot Therapeutics, Inc. email formats with LeadIQ.

How much funding has Carmot Therapeutics, Inc. raised to date?

Minus sign iconPlus sign icon As of February 2026, Carmot Therapeutics, Inc. has raised $150M in funding. The last funding round occurred on May 25, 2023 for $150M.

Carmot Therapeutics, Inc.

Biotechnology ResearchCalifornia, United States2-10 Employees

Carmot has been acquired by Roche in early 2024, making the company a member of the Roche Group. Carmot Therapeutics is a clinical-stage biotechnology company that is focused on advancing life-changing therapeutics for people with obesity and diabetes. We are utilizing Chemotype Evolution, a pioneering drug discovery platform, to identify novel incretin receptor signaling targets to develop a broad pipeline of therapeutics that have the potential to produce significant weight loss and improved glycemic control. We have three clinical candidates: CT-388, CT-868 and CT-996.

Section iconCompany Overview

Headquarters
Berkeley, California United States
Website
carmot-therapeutics.us
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
CRMO
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
2-10

Section iconMedia & News

Section iconFunding & Financials

  • $150M

    Carmot Therapeutics, Inc. has raised a total of $150M of funding over 8 rounds. Their latest funding round was raised on May 25, 2023 in the amount of $150M.

  • $1M$10M

    Carmot Therapeutics, Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $150M

    Carmot Therapeutics, Inc. has raised a total of $150M of funding over 8 rounds. Their latest funding round was raised on May 25, 2023 in the amount of $150M.

  • $1M$10M

    Carmot Therapeutics, Inc.'s revenue is estimated to be in the range of $1M$10M

Company Leadership

  • Stylized image of a person
    J. N.
    Associate Director, Accounting
    Phone icon
    Mobile Phone
  • Stylized image of a person
    L. A.
    Senior Clinical Trial Manager
    Phone icon
    Mobile Phone
  • Stylized image of a person
    D. E.
    Clinical Finance Manager
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. I.
    Senior Scientist
    Phone icon
    Mobile Phone
  • Stylized image of a person
    C. B.
    Executive Assistant
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    A. P.
    Research Associate
    Phone icon
    Mobile Phone
  • Stylized image of a person
    C. O.
    Help Desk Supervisor
    Phone icon
    Mobile Phone
  • Stylized image of a person
    D. L.
    Professor
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. M.
    Executive Assistant
    Phone icon
    Mobile Phone
  • Stylized image of a person
    D. J.
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.